30,035 Shares in Express Scripts (ESRX) Purchased by Great Lakes Advisors LLC

Great Lakes Advisors LLC bought a new stake in Express Scripts (NASDAQ:ESRX) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 30,035 shares of the company’s stock, valued at approximately $2,075,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Bank of New York Mellon Corp grew its holdings in Express Scripts by 8.7% in the 4th quarter. Bank of New York Mellon Corp now owns 8,287,905 shares of the company’s stock valued at $618,609,000 after buying an additional 666,754 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in Express Scripts by 5.7% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 7,190,246 shares of the company’s stock valued at $496,703,000 after buying an additional 388,601 shares during the last quarter. Geode Capital Management LLC grew its holdings in Express Scripts by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 6,608,383 shares of the company’s stock valued at $492,297,000 after buying an additional 32,548 shares during the last quarter. LSV Asset Management grew its holdings in Express Scripts by 3.4% in the 1st quarter. LSV Asset Management now owns 5,090,166 shares of the company’s stock valued at $351,628,000 after buying an additional 165,700 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. grew its holdings in Express Scripts by 4.0% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 3,847,820 shares of the company’s stock valued at $286,701,000 after buying an additional 147,293 shares during the last quarter. 88.20% of the stock is currently owned by hedge funds and other institutional investors.

Express Scripts stock opened at $73.24 on Wednesday. The company has a quick ratio of 0.56, a current ratio of 0.69 and a debt-to-equity ratio of 0.81. The company has a market cap of $41.38 billion, a P/E ratio of 9.74, a P/E/G ratio of 0.93 and a beta of 0.98. Express Scripts has a one year low of $73.08 and a one year high of $73.75.

Express Scripts (NASDAQ:ESRX) last posted its earnings results on Wednesday, May 2nd. The company reported $1.77 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.76 by $0.01. The business had revenue of $24.77 billion during the quarter, compared to the consensus estimate of $24.80 billion. Express Scripts had a return on equity of 25.41% and a net margin of 4.59%. Express Scripts’s revenue was up .5% on a year-over-year basis. During the same quarter last year, the company earned $1.33 EPS. equities research analysts forecast that Express Scripts will post 9.09 EPS for the current fiscal year.

A number of analysts have commented on ESRX shares. Zacks Investment Research downgraded Express Scripts from a “buy” rating to a “hold” rating in a research report on Friday, March 2nd. Jefferies Group set a $91.00 price objective on Express Scripts and gave the stock a “buy” rating in a research report on Wednesday, February 28th. BidaskClub upgraded Express Scripts from a “hold” rating to a “buy” rating in a research report on Friday, February 23rd. Sanford C. Bernstein downgraded Express Scripts from a “market perform” rating to an “underperform” rating and raised their price objective for the stock from $55.80 to $77.50 in a research report on Tuesday, January 30th. Finally, Bank of America started coverage on Express Scripts in a research report on Tuesday, February 27th. They issued an “underperform” rating and a $77.00 price objective for the company. Five analysts have rated the stock with a sell rating, twelve have given a hold rating and five have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $82.50.

In related news, VP Everett Neville sold 4,895 shares of the firm’s stock in a transaction that occurred on Thursday, March 1st. The stock was sold at an average price of $75.26, for a total transaction of $368,397.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Christine Houston sold 19,889 shares of the firm’s stock in a transaction that occurred on Thursday, March 15th. The stock was sold at an average price of $76.69, for a total value of $1,525,287.41. The disclosure for this sale can be found here. 0.79% of the stock is owned by company insiders.

About Express Scripts

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply